INIS
rats
100%
drugs
65%
patients
46%
wounds
39%
healing
33%
hospitals
33%
comparative evaluations
33%
control
27%
venoms
26%
snakes
26%
hiv
21%
evaluation
21%
therapy
21%
weight
21%
india
20%
doses
20%
toxicity
17%
administration
17%
diseases
17%
burns
16%
females
15%
adults
13%
assessments
13%
liver
13%
levels
13%
hemostatics
13%
pharmacology
13%
fluorides
13%
dexamethasone
12%
inflammation
10%
management
10%
males
10%
symptoms
9%
interactions
9%
psychological behavior
8%
morbidity
8%
enzyme inhibitors
7%
risks
7%
modifications
7%
WHO
6%
organs
6%
antidepressants
6%
ethanol
6%
myocardial infarction
6%
deoxyribonucleic acid
6%
recovery
6%
aluminium chlorides
6%
necrosis
6%
calcium
6%
methylation
6%
Pharmacology, Toxicology and Pharmaceutical Science
Rat
25%
HIV
21%
Wistar Rat
20%
Drug
17%
Wound
14%
Wound Healing
14%
Healing
12%
Dexamethasone
9%
Adverse Drug Reaction
9%
Symptom
8%
Pharmacokinetics
8%
Opportunistic Infection
7%
Malignant Neoplasm
6%
Neuroprotective Agent
6%
DNA
6%
Areca Catechu
6%
Tinospora cordifolia
6%
Oseltamivir
6%
Multiple Myeloma
6%
Tramadol
6%
Thalidomide
6%
Snake Venom
6%
Ethanol
6%
Morbidity
6%
Prescribing Drug
6%
Abortive Agent
6%
Envenomation
6%
Drug-Drug Interaction
6%
Hyaluronidase
6%
Vertigo
6%
Terminalia chebula
6%
Indian Cobra
6%
Naringin
6%
Nerve Degeneration
6%
Liver Disease
6%
Andrographis paniculata
6%
Lidocaine
6%
Tephrosia Purpurea
6%
Burn
6%
Macroglobulin
6%
Retrospective Study
6%
Liver Necrosis
6%
Albino Rat
6%
Toxicity
6%
Ferric Carboxymaltose
6%
Fluorosis
6%
Fluoride
5%
Adverse Event
5%
Diseases
5%
Observational Study
5%
Medicine and Dentistry
Patient
15%
Drug
13%
Chemotherapeutic Agent
13%
Wound Healing
7%
Hospital
7%
Incision
6%
Healing
6%
Toxicity
6%
Gender
6%
Body Weight
6%
Acute Heart Infarction
6%
Lidocaine
6%
Student
6%
Pseudomonic Acid
6%
Fusidate Sodium
6%
Diabetes Mellitus
6%
Age
6%
Catechu
6%
Discharge
6%
Assessment
6%
Tramadol
6%
Antiretroviral Therapy
6%
Cells
6%
Opportunistic Infection
6%
Medical Student
6%
Wound Infection
6%
Wound
6%
Hypolipemia
5%
ACE Inhibitor
5%
